Suppr超能文献

检测人类乳腺癌雌激素受体的单克隆抗体技术:与葡聚糖包被活性炭法相比,具有更高的灵敏度和更准确的受体状态分类。

Monoclonal antibody technique for detection of estrogen receptors in human breast cancer: greater sensitivity and more accurate classification of receptor status than the dextran-coated charcoal method.

作者信息

Thorpe S M

机构信息

Department of Nuclear Medicine, Finsen Institute, Copenhagen University Hospital, Denmark.

出版信息

Cancer Res. 1987 Dec 15;47(24 Pt 1):6572-5.

PMID:2445474
Abstract

Estrogen receptor (ER) concentrations have been determined in 191 freshly prepared cytosols from breast cancer biopsies using both the monoclonal enzyme immunoassay (ER-EIA) and the dextran-coated charcoal (ER-DCC) methods in a single laboratory. The concentrations of the ER detected using the two methods are highly and significantly correlated (linear regression curve: ER-EIA = 15.5 + 0.82 ER-DCC; r = 0.97). Nevertheless, it may be most correct to interpret the data by resolving the correlation into two lines, one describing the fit for cytosols with low and intermediate concentrations (the first 75% of the distribution of ER values for all primary breast cancers; less than 217 fmol ER/mg cytosol protein) and one describing the fit for cytosols with the highest ER concentrations (i.e., greater than or equal to 217 fmol ER/mg cytosol protein). Using a cutoff limit of 10 fmol/mg cytosol protein to distinguish between ER positive and ER negative biopsies, discrepancies in the classification of ER status were found in only 6% (12 of 191) of the cases using the two different methods. In all 12 cases, the ER concentrations as determined by both methods were in the lower range of receptor concentrations (0-53 fmol/mg cytosol protein). Of the 12 discrepancies, 10 biopsies were classified as ER negative using the ER-DCC method but ER positive using the ER-EIA method. Additional available data for these 10 patients indicate that the ER-EIA assay yielded the more biologically "correct" result. All 10 of these biopsies were either progesterone receptor positive or had nuclear ER. By identifying the outliers of the linear regression curves (points exceeding the 80% confidence interval) of the logarithmically transformed ER concentrations, 9 of the 12 biopsies were identified. Thus, it is unlikely that the observed discrepancies are due to random events in most cases here. Since most of the few deviations observed appear to represent true differences in the sensitivities of the two methods, the ER-EIA method appears to be superior to the ER-DCC method in our hands. The concentration of ER in 47 cytosols stored at -70 degrees C for 3-6 yr was analyzed using the ER-EIA method, and results were compared to the concentration of ER found using the ER-DCC method on freshly prepared cytosols when the biopsies had been received at the laboratory. The linear regression curve of the correlation between ER concentrations determined using the two methods did not differ significantly from that found for the 191 freshly prepared cytosols.

摘要

在同一实验室中,使用单克隆酶免疫测定法(ER-EIA)和葡聚糖包被活性炭法(ER-DCC),对191份新鲜制备的乳腺癌活检组织胞质溶胶中的雌激素受体(ER)浓度进行了测定。使用这两种方法检测到的ER浓度高度显著相关(线性回归曲线:ER-EIA = 15.5 + 0.82 ER-DCC;r = 0.97)。然而,将相关性分解为两条线来解释数据可能是最正确的,一条描述低浓度和中等浓度胞质溶胶的拟合情况(所有原发性乳腺癌ER值分布的前75%;ER浓度低于217 fmol ER/mg胞质溶胶蛋白),另一条描述最高ER浓度胞质溶胶的拟合情况(即大于或等于217 fmol ER/mg胞质溶胶蛋白)。使用10 fmol/mg胞质溶胶蛋白的临界值来区分ER阳性和ER阴性活检组织,在191例病例中,使用两种不同方法进行ER状态分类时,仅发现6%(12/191)的病例存在差异。在所有12例病例中,两种方法测定的ER浓度均处于受体浓度的较低范围(0 - 53 fmol/mg胞质溶胶蛋白)。在这12例差异中,10份活检组织使用ER-DCC法分类为ER阴性,但使用ER-EIA法分类为ER阳性。这10例患者的其他可用数据表明,ER-EIA测定法产生的结果在生物学上更“正确”。所有这10份活检组织要么孕激素受体阳性,要么有核ER。通过识别对数转换后的ER浓度线性回归曲线的异常值(超过80%置信区间的点),12份活检组织中的9份被识别出来。因此,在大多数情况下,观察到的差异不太可能是由于随机事件导致的。由于观察到的少数偏差大多似乎代表了两种方法灵敏度的真实差异,在我们手中,ER-EIA法似乎优于ER-DCC法。使用ER-EIA法分析了47份在-70℃储存3 - 6年的胞质溶胶中的ER浓度,并将结果与活检组织送达实验室时对新鲜制备的胞质溶胶使用ER-DCC法测得的ER浓度进行了比较。使用两种方法测定的ER浓度之间的相关性线性回归曲线与191份新鲜制备的胞质溶胶的曲线没有显著差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验